|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparable 3-year outcome following ABVD or BEACOPP first-line chemotherapy,plus preplanned high-dose salvage,in advanced Hodgkin lymphoma(HL):a randomized trial of the Michelangelo,GITIL and IIL cooperatives显示文摘 | Gianni AM Rambaldi A Zinzani P | 2008 | J Clin Oncol(ASCO Annual Meeting Abstracts)2008，，： | 1 |
| 2 | Differences in the expres- sion of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leuko- cytes显示文摘 | Rambaldi A Terao M Bettoni S | 1989 | Blood1989，73，5： | 1 |
| 3 | S-adenosyl-L-methionine for alcoholic li-ver diseases显示文摘 | Rambaldi A Gluud C | 2001 | Cochrane Database Syst Rev2001，，00： | 1 |
| 4 | Intensified chemo- immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma显示文摘 | Corradini P Vitolo U Rambaldi A | 2014 | Leukemia2014，28，9： | 1 |
| 5 | Anabolic-androgenic steroids for alco- holic liver disease 显示文摘 | Rambaldi A Gluud C | 2006 | Cochrane Database Syst Rev2006，，00： | 1 |
| 6 | Treat- ment of severe aplastic anemia with anti-lymphocyte globulin, cyclosporine and two different granulocyte colony stimulating factor regimens: a GITMO Prospective randomized study显示文摘 | LOCASCIULLI A BRUNO B RAMBALDI A | 2004 | J Haematologica2004，89，9： | 1 |
| 7 | Microhomalo- gies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia显示文摘 | Mattarucehi E Guerini V Rambaldi A | 2008 | Genes Chromosomes Cancer2008，47，7： | 1 |
| 8 | Milk thistle for alcoholic and/or hepatitis B or C liver diseases -asystematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials显示文摘 | Rambaldi A Jacobs BP Iaquinto G | 2005 | Am J Gastroenterol2005，100，11： | 1 |
| 9 | Cytokine Induced Killer(CIK) cells for the treatment of haematological neoplasms 显示文摘 | Introna M Golay J Rambaldi A | 2013 | Immunol Lett2013，155，12： | 1 |
| 10 | A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in pa- tients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea 显示文摘 | Verstovsek S Passamonti F Rambaldi A | 2014 | Cancer2014，120，4： | 1 |
| 11 | Safety and efficacy of everolimus, a roTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis显示文摘 | Guglielmelli P Barosi G Rambaldi A | 2011 | Blood2011，118，8： | 1 |
| 12 | Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis 显示文摘 | Rambaldi A Gluud C | 2005 | Cochrane Database Syst Rev2005，，00： | 1 |
| 13 | Hollow-fiber flow field-flow fractionation显示文摘 | Zattoni A Casolari S Rambaldi D C | 2007 | Current Anal Chem2007，3，4： | 1 |
| 14 | Treatment of severe aplastie anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens:a GITMO prospective randomized study显示文摘 | Locasciulli A Bruno B Rambaldi A | 2004 | Haematologica2004，89，9： | 1 |
| 15 | Milk thistle for alcoholic and/or hepatitis B or C liver disease-A Systematic Cochrane Hepato-Biliary Group Review with Meta-Analyses of Randomized Clinical Trails显示文摘 | Rambaldi A Jacobs BP Iaquinto G | 2005 | Am J Gastroenterol2005，100，11： | 1 |
| 16 | Flow cytometry of leucocyte alkaline phosphatase in normal and pathologic leucocytes显示文摘 | Rambaldi A Masuhara K Borleri GM | 1997 | Br J Haematol1997，96，： | 1 |
| 17 | Systematic review:glucocorticosteroids for alcoholic hepatitis-a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials显示文摘 | Rambaldi A Saconato HH Christensen E | 2008 | Aliment Pharmacol Ther2008，27，12： | 1 |
| 18 | RAR-alpha gene rear- rangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia 显示文摘 | Biondi A Rambaldi A Alcalay M | 1991 | Blood1991，77，7： | 1 |
| 19 | Durable responses with the JAK1 / JAK2 inhibitor, INCB018424, in patients with polycythemia vera ( PV ) and essential thrombocythemia ( ET ) refractory or intolerant to hydroxyurea ( HU ) 显示文摘 | Verstovsek S Passamonti F Rambaldi A | 2010 | Blood2010，116，21： | 1 |
| 20 | Durable responses with the JAK1/JAK2 inhibitor INCBO18424, in patients with polycythemia vera ( PV ) and essential thrombocythemia ( ET ) refractory or intolerant to hydroxyurea ( HU ) 显示文摘 | Verstovsek V Passamonti F Rambaldi A | 2010 | Blood ( ASH Annual Meeting Abstracts )2010，116，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员